newsfilter
← Latest News
Business Wire·

4D pharma to Participate in Jefferies London Healthcare Conference

4D pharma plc ((AIM: DDDD, NASDAQ:LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that 4D pharma management will participate in the Jeffer